While GLUT1 has traditionally been recognized as a key player in cancer glucose metabolism, recent studies have revealed the expression of SGLTs, particularly SGLT1 and SGLT2, in certain cancer types [39,[56], [57], [58], [59], [60], [61], [62], [63]] (Table 2). The gene discussed is SLC5A2; the disease is cancer.